A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.
Bacillus anthracis, the etiological agent of anthrax, is a major bioterror agent. Vaccination is the most effective prophylactic measure available against anthrax. Currently available anthrax vaccines have issues of the multiple booster dose requirement, adjuvant-associated side effects and stabilit...
Guardado en:
Autores principales: | Manish Manish, Amit Rahi, Manpreet Kaur, Rakesh Bhatnagar, Samer Singh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9d2c9cc36e3461183a7ce93b72efd9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus Anthracis
por: Keyhan AH, Tahmasbpour Marzony E, Farhadi N, Kamali M
Publicado: (2011) -
ANALYSIS OF TOXIN-NEUTRALIZING ACTIVITY OF MOUSE MONOCLONAL ANTIBODIES AGAINST PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS
por: N. A. Zeninskaya, et al.
Publicado: (2018) -
Author Correction: Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores
por: Jamie S. Benn, et al.
Publicado: (2021) -
A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis
por: Saugata Majumder, et al.
Publicado: (2018) -
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
por: B. Kim Lee Sim, et al.
Publicado: (2017)